The Schall Law Firm Launches Examination Of Allegations Against Regeneron Pharmaceuticals Inc And Invites Suffering Investors To Reach Out
StockNews.AI • 589 days
Low Materiality0/10
Information
LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights lit...
Original sourceAI Summary
The Schall Law Firm investigating Regeneron Pharmaceuticals, Inc. for securities law violations. Regeneron accused of failing to disclose millions in price concessions to drug distributors. Lawsuit alleges higher selling price for Eylea product than Medicare allowed.
Market-Moving
- The Schall Law Firm investigating Regeneron Pharmaceuticals, Inc. for securities law violations.
- Regeneron accused of failing to disclose millions in price concessions to drug distributors.
- Lawsuit alleges higher selling price for Eylea product than Medicare allowed.
Key Facts
- The Schall Law Firm investigating Regeneron Pharmaceuticals, Inc. for securities law violations.
- Regeneron accused of failing to disclose millions in price concessions to drug distributors.
- Lawsuit alleges higher selling price for Eylea product than Medicare allowed.